Promoting cervical cancer screening via a mailed HPV self-collection kit: Reactions from screeners and non-screeners
Patient Education and Counseling · 2026
DOI: 10.1016/j.pec.2025.109374 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Patient Education and Counseling, 2026. Verfasst von Jasmin A Tiro und 14 weiteren Autor:innen. Beteiligte Einrichtung: Biological Sciences Division, Department of Public Health Sciences, University of Chicago, Chicago, IL, USA. Electronic address: jtiro@bsd.uchicago.e…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Early Detection of Cancer, Mass Screening. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Kaiser Permanente Washington Health Research Institute, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
OBJECTIVE: Mailed human papillomavirus self-collection (HPV-SC) kits improve cervical cancer screening adherence; however, not all respond to kit invitations. This qualitative study sought to understand reactions to HPV-SC kit invitation among screeners and non-screeners in the STEP trial, a pragmatic trial offering kits. METHODS: Kaiser Permanente Washington patients randomized to the STEP trial's kit intervention arms, received educational materials and were notified they would receive a kit in one week (direct mail) or given information on how to request a kit (opt-in). Materials highlighted cancer risk, screening importance, test differences (Pap, HPV), and what to expect with abnormal results. Based on their screening status 6 months post-randomization, two categories of patients were invited for focus groups: 1) screeners with negative kit results or clinician-performed test; 2) non-screeners. We oversampled non-white patients. Six online focus groups were conducted from May to June 2022 with 40 patients (29 screeners, 11 non-screeners). A facilitator asked about HPV and cervical cancer knowledge, reaction to the kit and educational materials, and screening preference (self- vs. clinician-collected). Field notes and transcripts were analyzed by five coders using iterative content analysis. RESULTS: Participants desired more flexibility during the invitation process, preferring multiple methods (mail, patient portal, text, in-clinic distribution) and support services (website, nurse-staffed phone). Educational resources acknowledging different learning styles (print, diagrams, audio-visual) and for specific populations (LGBTQ, monogamous) were suggested. Participants recommended clinicians reinforce kit efficacy to encourage use. Trust in the kit and in the health care system were key to ensure comfort with self-collection. CONCLUSION: Multiple, diverse outreach strategies are needed to engage patients in screening with this new modality. PRACTICE IMPLICATIONS: Flexible engagement by the healthcare system with comprehensive educational materials inclusive of diverse populations, and provider encouragement are needed to build patients' trust in, comfort with, and use of HPV-SC tests. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04679675.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biological Sciences Division, Department of Public Health Sciences, University of Chicago, Chicago, IL, USA. Electronic address: jtiro@bsd.uchicago.edu.
- Biological Sciences Division, Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.
- Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, Saint Louis, MO, USA.
- Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
- Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA.
- Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
Förderung
- NCI NIH HHS
- Kaiser Permanente Washington Health Research Institute
- National Heart, Lung, and Blood Institute
- Patient-Centered Outcomes Research Institute
- Grail
- National Cancer Institute
Zitieren
APA
Tiro, J. A., Metcalfe, S., Muthukrishnan, M., Jose, A., Hansen, K., Lin, J., Dorsey, C. N., Gao, H., Lacey, C., Anderson, M. L., Meenan, R. T., Green, B. B., Buist, D. S. M., Sparks, A., & Winer, R. L. (2026). Promoting cervical cancer screening via a mailed HPV self-collection kit: Reactions from screeners and non-screeners. Patient Education and Counseling. https://doi.org/10.1016/j.pec.2025.109374
Vancouver
Tiro JA, Metcalfe S, Muthukrishnan M, Jose A, Hansen K, Lin J, et al. Promoting cervical cancer screening via a mailed HPV self-collection kit: Reactions from screeners and non-screeners. Patient Education and Counseling. 2026. doi:10.1016/j.pec.2025.109374
BibTeX
@article{Tiro2026,
author = {Tiro, Jasmin A and Metcalfe, Sadie and Muthukrishnan, Meera and Jose, Angelina and Hansen, Kris and Lin, John and Dorsey, Caitlin N and Gao, Hongyuan and Lacey, Catherine and Anderson, Melissa L and Meenan, Richard T and Green, Beverly B and Buist, Diana S M and Sparks, Angela and Winer, Rachel L},
title = {Promoting cervical cancer screening via a mailed HPV self-collection kit: Reactions from screeners and non-screeners},
journal = {Patient Education and Counseling},
year = {2026},
doi = {10.1016/j.pec.2025.109374}
}
EUVIMED